Skip to main content
. 2022 Jul 1;50:101509. doi: 10.1016/j.eclinm.2022.101509

Table 1.

Characteristics of included studies.

Study Country Setting Sample size Male (%) Age (years) Inclusion criteria Exclusion criteria Measure of depression Baseline depression Intervention period
Chan (2009)29 Hong Kong Day-care centers or homes 50 44.7 75-79 years: 23% Aged ≥60 years NR GDS Int: 13.1 (5.2); Ctrl: 13.4 (4.4) 4
Chan (2010)30 Hong Kong Homes 42 45.2 80+ years: 35.7% Aged ≥60 years Deaf; altered mental status; cognitive impairment; or had a recent death in the family GDS-SF Int: 4.1 (4.0); Ctrl: 1.8 (1.7) 4
Chu (2014)31 Taiwan Nursing homes 100 47.0 82.0 (6.8) Aged ≥60 years; diagnosis of dementia Receptive language problem; inability to participate in an intervention for at least 30 min C-CSDD Int: 17.4 (9.6); Ctrl: 15.7 (10.2) 6
Coulton (2015)32 UK Community singing club 258 16.1 69.2 (7.1) Aged ≥60 years Unable to provide informed consent HADS Int: 4.6 (3.5); Ctrl: 4.2 (3.5) 14
Gok Ugur (2017)33 Turkey Nursing homes 64 NR 76.4 (NR) People who had lived in a nursing home Any visual or hearing loss GDS-SF Int: 8.1 (2.4); Ctrl: 8.5 (3.1) 8
Guetin (2009)34 France Homes 30 26.7 86.1 (NR) Aged 70-95 years; mild to moderate AD; MMSE score 12-25; HAS score ≥12 Suffering from a life-threatening illness; neurological disorders, stroke PD, epilepsy, dementia; and psychiatric disorder GDS Int: 16.7 (6.2); Ctrl: 11.8 (7.4) 16
Hanser (1994)35 US Homes 30 23.0 67.9 (NR) Older adults; diagnosis of major or minor depression NR GDS Int: 17.4 (6.7); Ctrl: 15.3 (5.8) 8
Liu (2021)36 Taiwan Veteran's homes 50 100.0 86.6 (4.5) Aged ≥75 years; mild to moderate AD; mild anxiety; receiving stable psychotropic or anxiolytic treatment for 3 months NR GDS-SF Int: 4.7 (0.5); Ctrl: 4.7 (0.5) 12
Mahendran (2018)37 Singapore Community research center 46 17.4 71.1 (NR) Aged ≥75 years; mild cognitive impairment Dementia/major neurocognitive disorder; major psychiatric disorder; terminal illness; visual and/or hearing impairment GDS-SF Int: 1.8 (2.2); Ctrl: 2.8 (2.9) 36
Mathew (2017)38 India Nursing homes 80 50.0 NR (all 65+) Aged ≥65 years; GDS-SF score 5-8 On anti-depressive medication, or other medications affecting sleep or mood disorders; hearing problems GDS-SF Int: 7.8 (1.1); Ctrl: 8.1 (0.9) 3
Murabayashi (2019)39 Japan Therapy rooms 94 6.4 81.3 (5.5) Aged 65-89 years; having one or more care needs regarding social withdrawal, dementia, or depression NR GDS-SF NR 12
Perez-Ros (2019)40 Spain Nursing homes 119 48.7 80.5 (7.4) Aged ≥65 years; diagnosis of dementia Terminally ill patients CSDD Int: 5.0 (4.5); Ctrl: 8.0 (5.9) 8
Raglio (2015)41 Italy Nursing homes and day care centers 120 21.7 81.7 (NR) Aged ≥65 years; diagnosis of dementia; MMSE ≤18 Severe cardiovascular, pulmonary, or gastrointestinal disease CSDD Int 1: 9.0 (4.1); Int 2: 10.0 (4.8); Ctrl: 8.0 (6.7) 10
Robertson-Gillam (2008)42 Australia Aged care facility 30 30.0 82.6 (5.8) Resident of the aged care facility; diagnosis of dementia NR CSDD Int: 10.5 (8.9); Ctrl: 8.9 (5.4) 12
Yap (2017)43 Singapore Homes 31 6.0 74.6 (6.4) Aged ≥65 years On palliative care, bed-bound CSDD-SF Int: 3.5 (1.0, 6.0); Ctrl: 6.0 (3.0, 8.0) 10

*Mean (standard deviation).

Interquartile range.

Abbreviations: AD=Alzheimer disease; C-CSDD=Chinese version of the Cornell Scale for Depression in Dementia; CSDD=Cornell Scale for Depression in Dementia; Ctrl=Control; GDS=Geriatric Depression Scale; GDS-SF= Geriatric Depression Scale Short Form; HADS=Hospital Anxiety and Depression Scale; HAS=Hamilton Anxiety Scale; Int=Intervention; MMSE=Mini Mental State Evaluation; NR=Not Reported.